Observe Medical ASA, 28 February 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 24 January 2020 regarding the exercise of employee share options and issue of 275,000 new shares in the Company. The NOK 71,500 share capital increase pertaining to the exercise of the employee share options…
Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value…
(Oslo, 24 January 2020) Exercise of employee share options In connection with the expiry date at 24 January three employees in Navamedic ASA have exercised a total of 275,000 options in Observe Medical ASA. Employees in Navamedic ASA were granted options in Observe Medical ASA in connection with the demerger of Navamedic ASA’s Medtech division…
Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The…
Financial calendar for Observe Medical ASA FINANCIAL YEAR 2019 17.04.2020 – Annual Report 03.06.2020 – Annual General Meeting 25.02.2020 – Quarterly Report – Q4 FINANCIAL YEAR 2020 18.08.2020 – Half-yearly Report 12.05.2020 – Quarterly Report – Q1 03.11.2020 – Quarterly Report – Q3 This information is published pursuant to the requirements set out in…
Oslo, 9 December 2019: Observe Medical ASA (“Observe Medical”) today announces that Per Arne Nygård is appointed interim Chief Financial Officer of the company for the period 9 December, 2019 to 1 March, 2020. Per Arne Nygård has been with Navamedic ASA as a consultant since August, 2019. He has held several executive financial positions…
Observe Medical ASA, 1 November 2019: Reference is made to Navamedic ASA's ("NAVA") and Observe Medical ASA's ("Observe Medical") stock exchange announcements dated 30 October 2019 and 31 October 2019, regarding Oslo Børs' approval of Observe Medical's application for listing of its shares on Oslo Axess (the "Listing") and the completion of the demerger of…
Observe Medical ASA, 1 November 2019: On 1 October 2019, the general meeting of Observe Medical ASA (the "Company) resolved to increase the share capital of the Company with NOK 832,000 by issuance of 3,200,000 new shares to Navamedic ASA, each with a nominal value of NOK 0.26, by way of set-off against a receivable…
Reference is made to the announcement from Navamedic ASA 31.10.2019 The shares in Navamedic ASA will today be traded exclusive of rights to consideration shares in Observe Medical ASA.
Observe Medical ASA, 31 October 2019: Reference is made to Navamedic ASA's ("NAVA") previous stock exchange announcements regarding the proposed demerger of NAVA with transfer to Observe Medical ASA (the "Company" or "Observe Medical"). Today, on 31 October 2019, after the close of trading on the Oslo Stock Exchange, completion of the demerger of NAVA…
Navamedic ASA, 31 October 2019: The shares in Navamedic ASA ("NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged…
Observe Medical ASA, 30 October 2019: Reference is made to the previous stock exchange notices made by Navamedic ASA ("NAVA") on 19 June 2019 and 5 August 2019 regarding the demerger of NAVA, whereby inter alia NAVA's Medtech division is demerged from NAVA and merged into Observe Medical ASA (the "Company" or "Observe Medical"), which…
Oslo Børs has resolved to admit the shares in Observe Medical ASA to listing on Oslo Axess. It is stipulated that the company prior to the first day of listing must satisfy the listing requirements on Oslo Axess. The Chief Executive Officer of the Oslo Stock Exchange determines the date of the first day of…
Observe Medical ASA: New CEO appointed and board authorisation to increase the share capital of the company proposed by the board and approved by the extraordinary general meeting. Oslo, 24 October 2019: Observe Medical ASA (the "Company") today announces that Björn Larsson is appointed Chief Executive Officer of the Company effective mid-December 2019. Mr. Larsson…
Oslo Børs has received a request for admission to trading from Observe Medical ASA on Oslo Axess. The disclosure of information requirement set out in sections 5-1, 5-2 and 5-3 of the Securities Trading Act, will apply from the time a request for admission to trading on the stock exchange has been made. Company… Observe Medical ASA – Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Q4 2019 financial results
Observe Medical ASA: Exercise of employee share options and increased share capital
Share options granted
Financial calendar
Observe Medical ASA: Interim CFO appointed
Observe Medical ASA – Approval and publication of listing prospectus
Observe Medical ASA – Registration of share capital increase following completing of debt conversion
Eks rights to consideration shares in Observe Medical ASA
Completion of the demerger of Navamedic ASA; registration of changes in the share capital of Observe Medical ASA and amendment of articles of association of Observe Medical ASA
Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA
Observe Medical ASA – Oslo Børs approves listing of Observe Medical ASA on Oslo Axess
The Oslo Stock Exchange approves Observe Medical ASA for listing on Oslo Axess
Observe Medical ASA – New CEO appointed and board authorisation approved
Oslo Børs – Received application for listing – Observe Medical ASA